1-20 of 22
Beverly A. Teicher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission

Kenneth C. Anderson, Lewis C. Cantley, Riccardo Dalla-Favera, Chi Van Dang, Luis A. Diaz, Raymond N. DuBois, Keith T. Flaherty, Philip D. Greenberg, Massimo Loda, Elaine R. Mardis, Elizabeth A. Platz, Michael N. Pollak, Robert D. Schreiber, Lillian L. Siu, Beverly A. Teicher
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (21): 4593–4599.
https://doi.org/10.1158/1078-0432.CCR-22-3167
Published: 01 November 2022
View article titled, The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission
Open the PDF for The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission in another window
Journal Articles

The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models

Nathan M. Kendsersky, Jarrett Lindsay, E. Anders Kolb, Malcolm A. Smith, Beverly A. Teicher, Stephen W. Erickson, Eric J. Earley, Yael P. Mosse, Daniel Martinez, Jennifer Pogoriler, Kateryna Krytska, Khushbu Patel, David Groff, Matthew Tsang, Samson Ghilu, Yifei Wang, Steven Seaman, Yang Feng, Brad St. Croix, Richard Gorlick, Raushan Kurmasheva, Peter J. Houghton, John M. Maris
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (10): 2938–2946.
https://doi.org/10.1158/1078-0432.CCR-20-4221
Published: 15 May 2021
View article titled, The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models
Open the PDF for The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models in another window
Includes: Supplementary data
Journal Articles

OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL

Kathryn Evans, JianXin Duan, Tara Pritchard, Connor D. Jones, Lisa McDermott, Zhaohui Gu, Cara E. Toscan, Narimanne El-Zein, Chelsea Mayoh, Stephen W. Erickson, Yuelong Guo, Fanying Meng, Donald Jung, Komal S. Rathi, Kathryn G. Roberts, Charles G. Mullighan, Chi-Sheng Shia, Tillman Pearce, Beverly A. Teicher, Malcolm A. Smith, Richard B. Lock
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (14): 4493–4503.
https://doi.org/10.1158/1078-0432.CCR-19-0551
Published: 15 July 2019
View article titled, OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL
Open the PDF for OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL in another window
Includes: Supplementary data
Journal Articles

Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models

Caitlin D. Lowery, Michele Dowless, Matthew Renschler, Wayne Blosser, Alle B. VanWye, Jennifer R. Stephens, Philip W. Iversen, Aimee Bence Lin, Richard P. Beckmann, Kateryna Krytska, Kristina A. Cole, John M. Maris, Douglas S. Hawkins, Brian P. Rubin, Raushan T. Kurmasheva, Peter J. Houghton, Richard Gorlick, E. Anders Kolb, Min H. Kang, C. Patrick Reynolds, Stephen W. Erickson, Beverly A. Teicher, Malcolm A. Smith, Louis F. Stancato
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (7): 2278–2289.
https://doi.org/10.1158/1078-0432.CCR-18-2728
Published: 01 April 2019
View article titled, Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models
Open the PDF for Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models in another window
Includes: Supplementary data
Journal Articles

PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer

Benjamin H. Lok, Eric E. Gardner, Valentina E. Schneeberger, Andy Ni, Patrice Desmeules, Natasha Rekhtman, Elisa de Stanchina, Beverly A. Teicher, Nadeem Riaz, Simon N. Powell, John T. Poirier, Charles M. Rudin
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (2): 523–535.
https://doi.org/10.1158/1078-0432.CCR-16-1040
Published: 15 January 2017
View article titled, PARP Inhibitor Activity Correlates with <em>SLFN11</em> Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer
Open the PDF for PARP Inhibitor Activity Correlates with <em>SLFN11</em> Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

CCR 20th Anniversary Commentary: In the Beginning, There Was PS-341

Beverly A. Teicher, Kenneth C. Anderson
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 939–941.
https://doi.org/10.1158/1078-0432.CCR-14-2549
Published: 01 March 2015
View article titled, <em>CCR</em> 20<sup>th</sup> Anniversary Commentary: In the Beginning, There Was PS-341
Open the PDF for <em>CCR</em> 20<sup>th</sup> Anniversary Commentary: In the Beginning, There Was PS-341 in another window
Journal Articles

Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma

Chand Khanna, Timothy M. Fan, Richard Gorlick, Lee J. Helman, Eugenie S. Kleinerman, Peter C. Adamson, Peter J. Houghton, William D. Tap, Danny R. Welch, Patricia S. Steeg, Glenn Merlino, Poul H.B. Sorensen, Paul Meltzer, David G. Kirsch, Katherine A. Janeway, Brenda Weigel, Lor Randall, Stephen J Withrow, Melissa Paoloni, Rosandra Kaplan, Beverly A. Teicher, Nita L. Seibel, Malcolm Smith, Aykut Üren, Shreyaskumar R. Patel, Jeffrey Trent, Sharon A. Savage, Lisa Mirabello, Denise Reinke, Donald A. Barkaukas, Mark Krailo, Mark Bernstein
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (16): 4200–4209.
https://doi.org/10.1158/1078-0432.CCR-13-2574
Published: 13 August 2014
View article titled, Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma
Open the PDF for Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma in another window
Journal Articles

Targeting Cancer Metabolism

Beverly A. Teicher, W. Marston Linehan, Lee J. Helman
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (20): 5537–5545.
https://doi.org/10.1158/1078-0432.CCR-12-2587
Published: 14 October 2012
View article titled, Targeting Cancer Metabolism
Open the PDF for Targeting Cancer Metabolism in another window
Journal Articles

Antibody Conjugate Therapeutics: Challenges and Potential

Beverly A. Teicher, Ravi V.J. Chari
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (20): 6389–6397.
https://doi.org/10.1158/1078-0432.CCR-11-1417
Published: 14 October 2011
View article titled, Antibody Conjugate Therapeutics: Challenges and Potential
Open the PDF for Antibody Conjugate Therapeutics: Challenges and Potential in another window
Journal Articles

Genz-644282, a Novel Non-Camptothecin Topoisomerase I Inhibitor for Cancer Treatment

Leslie S. Kurtzberg, Stephanie Roth, Roy Krumbholz, Jennifer Crawford, Christy Bormann, Sarah Dunham, Min Yao, Cecile Rouleau, Rebecca G. Bagley, Xian-Jie Yu, Fei Wang, Steven M. Schmid, Edmond J. LaVoie, Beverly A. Teicher
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (9): 2777–2787.
https://doi.org/10.1158/1078-0432.CCR-10-0542
Published: 01 May 2011
View article titled, Genz-644282, a Novel Non-Camptothecin Topoisomerase I Inhibitor for Cancer Treatment
Open the PDF for Genz-644282, a Novel Non-Camptothecin Topoisomerase I Inhibitor for Cancer Treatment in another window
Journal Articles

Placental Growth Factor Upregulation Is a Host Response to Antiangiogenic Therapy

Rebecca G. Bagley, Yi Ren, William Weber, Min Yao, Leslie Kurtzberg, Jason Pinckney, Dinesh Bangari, Cokey Nguyen, William Brondyk, Johanne Kaplan, Beverly A. Teicher
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (5): 976–988.
https://doi.org/10.1158/1078-0432.CCR-10-2687
Published: 01 March 2011
View article titled, Placental Growth Factor Upregulation Is a Host Response to Antiangiogenic Therapy
Open the PDF for Placental Growth Factor Upregulation Is a Host Response to Antiangiogenic Therapy in another window
Journal Articles

CXCL12 (SDF-1)/CXCR4 Pathway in Cancer

Beverly A. Teicher, Simon P. Fricker
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (11): 2927–2931.
https://doi.org/10.1158/1078-0432.CCR-09-2329
Published: 31 May 2010
View article titled, CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
Open the PDF for CXCL12 (SDF-1)/CXCR4 Pathway in Cancer in another window
Journal Articles

Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008

Paul Okunieff, Lisa A. Kachnic, Louis S. Constine, Clifton D. Fuller, Laurie E. Gaspar, Daniel F. Hayes, Jean Hooks, Clifton Ling, Frank L. Meyskens, Jr., Philip A. Philip, David Raben, Stephen R. Smalley, Gregory P. Swanson, Beverly A. Teicher, Charles R. Thomas, Jr., Bhadrasain Vikram, Michael J. Zelefsky, Laurence H. Baker
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (18): 5663–5670.
https://doi.org/10.1158/1078-0432.CCR-09-0357
Published: 14 September 2009
View article titled, Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008
Open the PDF for Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008 in another window
Journal Articles

Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma

Cecile Rouleau, Maritza Curiel, William Weber, Robert Smale, Leslie Kurtzberg, James Mascarello, Carol Berger, Gina Wallar, Rebecca Bagley, Nakayuki Honma, Kazumasa Hasegawa, Isao Ishida, Shiro Kataoka, Beth L. Thurberg, Khodadad Mehraein, Bruce Horten, Glenn Miller, Beverly A. Teicher
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (22): 7223–7236.
https://doi.org/10.1158/1078-0432.CCR-08-0499
Published: 14 November 2008
View article titled, Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma
Open the PDF for Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma in another window
Includes: Supplementary data
Journal Articles

Newer Cytotoxic Agents: Attacking Cancer Broadly

Beverly A. Teicher
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (6): 1610–1617.
https://doi.org/10.1158/1078-0432.CCR-07-2249
Published: 17 March 2008
View article titled, Newer Cytotoxic Agents: Attacking Cancer Broadly
Open the PDF for Newer Cytotoxic Agents: Attacking Cancer Broadly in another window
Journal Articles

Transforming Growth Factor-β and the Immune Response to Malignant Disease

Beverly A. Teicher
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (21): 6247–6251.
https://doi.org/10.1158/1078-0432.CCR-07-1654
Published: 01 November 2007
View article titled, Transforming Growth Factor-β and the Immune Response to Malignant Disease
Open the PDF for Transforming Growth Factor-β and the Immune Response to Malignant Disease in another window
Journal Articles

Protein Kinase C as a Therapeutic Target

Beverly A. Teicher
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (18): 5336–5345.
https://doi.org/10.1158/1078-0432.CCR-06-0945
Published: 25 September 2006
View article titled, Protein Kinase C as a Therapeutic Target
Open the PDF for Protein Kinase C as a Therapeutic Target in another window
Journal Articles

Murine Endothelial Cell Lines as Models of Tumor Endothelial Cells

Jennifer Walter-Yohrling, Sharon Morgenbesser, Cecile Rouleau, Rebecca Bagley, Michelle Callahan, William Weber, Beverly A. Teicher
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (6): 2179–2189.
https://doi.org/10.1158/1078-0432.CCR-03-1013
Published: 24 March 2004
View article titled, Murine Endothelial Cell Lines as Models of Tumor Endothelial Cells
Open the PDF for Murine Endothelial Cell Lines as Models of Tumor Endothelial Cells in another window
Journal Articles

Properties of Bisphosphonates in the 13762 Rat Mammary Carcinoma Model of Tumor-Induced Bone Resorption

Enrique Alvarez, Michael Westmore, Rachelle J. Sells Galvin, Crystal L. Clapp, Eileen L. Considine, Shawn J. Smith, Kristan Keyes, Philip W. Iversen, Dawn M. Delafuente, Shola Sulaimon, Carmen Zambrano, Linda Ma, Masahiko Sato, T. John Martin, Beverly A. Teicher, Elizabeth J. Galbreath
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (15): 5705–5713.
Published: 03 December 2003
View article titled, Properties of Bisphosphonates in the 13762 Rat Mammary Carcinoma Model of Tumor-Induced Bone Resorption
Open the PDF for Properties of Bisphosphonates in the 13762 Rat Mammary Carcinoma Model of Tumor-Induced Bone Resorption in another window
Journal Articles

Antiangiogenic and Antitumor Effects of a Protein Kinase Cβ Inhibitor in Human T98G Glioblastoma Multiforme Xenografts

Beverly A. Teicher, Krishna Menon, Enrique Alvarez, Elizabeth Galbreath, Chuan Shih, Margaret Faul
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (3): 634–640.
Published: 01 March 2001
View article titled, Antiangiogenic and Antitumor Effects of a Protein Kinase Cβ Inhibitor in Human T98G Glioblastoma Multiforme Xenografts
Open the PDF for Antiangiogenic and Antitumor Effects of a Protein Kinase Cβ Inhibitor in Human T98G Glioblastoma Multiforme Xenografts in another window